Sequence-dependent antagonism between fluorouracil and paclitaxel in human breast cancer cells
- 1 August 1999
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 58 (3) , 477-486
- https://doi.org/10.1016/s0006-2952(99)00099-4
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Cytotoxicity and DNA damage associated with pyrazoloacridine in MCF-7 breast cancer cellsBiochemical Pharmacology, 1996
- Taxanes: A New Class of Antitumor AgentsCancer Investigation, 1995
- Computerized Quantitation of Synergism and Antagonism of Taxol, Topotecan, and Cisplatin Against Human Teratocarcinoma Cell Growth: a Rational Approach to Clinical Protocol DesignJNCI Journal of the National Cancer Institute, 1994
- Role of Modelling in Joint Action StudiesJNCI Journal of the National Cancer Institute, 1994
- Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotubule agents taxol and vincristineZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- Taxol in combination with doxorubicin or etoposide possible antagonism in vitroCancer, 1993
- Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations.Proceedings of the National Academy of Sciences, 1993
- Assembly of purified GDP-tubulin into microtubules induced by taxol and taxotere: Reversibility, ligand stoichiometry, and competitionBiochemistry, 1993
- A specialized form of chromosomal DNA degradation induced by thymidylate stress in mouse FM3A cellsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1988
- Taxol: an antimitotic agent with a new mechanism of actionPharmacology & Therapeutics, 1984